Openbookopenbook
Equity
IBT
+0.0 · +0.00%
GBX · LSE

International Biotechnology Trust plc(IBT) Stock Analysis | Healthcare

GBX --+0.00%
Reward59Moderate
Risk22Low
75%Data
Strong 96% profit margin · 2.8% dividend yield · Revenue growing 592% YoY
Defensive Anchor
Market Cap:359.83M
ⓘ
Reward Rating
59
Moderate
Reward Assessment
75% data coverage
Top 50% of stocksView factors
ⓘ
Risk Rating
22
Low
Risk Assessment
4 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on IBT to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for IBT, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is International Biotechnology Trust plc?

International Biotechnology Trust plc specializes in investments in development stage and late stage companies.

IBT · Verdict

Solid reward · low risk

IBT scores well on volatility and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

IBT · Verdict

What’s working & what to watch

Strengths 5

  • Volatility95/100

    Top decile vs peers

  • Cash flow71/100

    199% free-cash-flow margin

  • Balance sheet69/100

    Current ratio 7.30

  • Profitability67/100

    -8% net margin · 26% ROE

  • Valuation67/100

    P/E 714.3×

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is International Biotechnology Trust plc?

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 359.83M, and a P/E ratio of 4.7x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Adequate profitability with some margin variability in recent periods.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (59)

The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.

AVCTMicro Cap / 300M market cap
Avacta Group PLC
Compare
PRTCMicro Cap / 289M market cap
PureTech Health plc
Compare
OXBSmall Cap / 589M market cap
Oxford BioMedica PLC
Compare
Company Information
SectorHealthcare
IndustryBiotechnology
Market Cap359.83M
P/E Ratio4.6901
Dividend Yield2.79%
Beta0.312
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.